We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$407M
AUM Growth
-$38.3M
Cap. Flow
-$52.4M
Cap. Flow %
-12.88%
Top 10 Hldgs %
19.3%
Holding
282
New
19
Increased
67
Reduced
110
Closed
63

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$6.14M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$5.93M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$5.36M
4
ALBO
Albireo Pharma Inc
ALBO
+$1.07M
5
ZYME icon
Zymeworks
ZYME
+$808K

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$8.83M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.78M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$4.57M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.53M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$966K

Sector Composition

Rank Sector Weight
1 Industrials 19.96%
2 Technology 18%
3 Healthcare 15.75%
4 Materials 7.84%
5 Financials 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCI icon
51
Crown Castle
CCI
$34.6B
$2.18M 0.54%
19,565
-396
-2% -$44.1K
SPG icon
52
Simon Property Group
SPG
$74.2B
$2.13M 0.52%
12,061
-872
-7% -$154K
INTC icon
53
Intel
INTC
$478B
$2.11M 0.52%
44,608
-822
-2% -$40K
JCI icon
54
Johnson Controls International
JCI
$85.7B
$2.1M 0.52%
59,938
-2,452
-4% -$90.4K
SLB icon
55
SLB Ltd
SLB
$70.3B
$2.05M 0.5%
33,722
-746
-2% -$48K
AEP icon
56
American Electric Power
AEP
$71.9B
$2.05M 0.5%
28,967
-593
-2% -$42.2K
OTTR icon
57
Otter Tail
OTTR
$3.9B
$1.99M 0.49%
41,608
-703
-2% -$34K
KEY icon
58
KeyCorp
KEY
$25.4B
$1.99M 0.49%
99,922
-4,030
-4% -$83.7K
CVS icon
59
CVS Health
CVS
$137B
$1.98M 0.49%
25,095
-795
-3% -$56.8K
VER
60
DELISTED
VEREIT, Inc.
VER
$1.95M 0.48%
53,647
-1,930
-3% -$73.6K
ABBV icon
61
AbbVie
ABBV
$450B
$1.95M 0.48%
20,574
-387
-2% -$36.7K
HBAN icon
62
Huntington Bancshares
HBAN
$37B
$1.94M 0.48%
130,128
-5,320
-4% -$83.2K
VOO icon
63
Vanguard S&P 500 ETF
VOO
$974B
$1.92M 0.47%
7,173
-166
-2% -$43.4K
SNY icon
64
Sanofi
SNY
$107B
$1.89M 0.46%
42,365
-873
-2% -$37.3K
LYB icon
65
LyondellBasell Industries
LYB
$19.1B
$1.85M 0.46%
18,070
-590
-3% -$64.5K
BXMT icon
66
Blackstone Mortgage Trust
BXMT
$2.88B
$1.85M 0.45%
55,158
-836
-1% -$27.9K
EQR icon
67
Equity Residential
EQR
$25.9B
$1.77M 0.44%
26,772
-1,280
-5% -$84.7K
CBT icon
68
Cabot Corp
CBT
$4.67B
$1.77M 0.44%
28,244
-1,219
-4% -$78.4K
SAFT icon
69
Safety Insurance
SAFT
$1.09B
$1.73M 0.42%
19,287
-841
-4% -$77.7K
PH icon
70
Parker-Hannifin
PH
$120B
$1.72M 0.42%
9,324
-77
-0.8% -$13.2K
DUK icon
71
Duke Energy
DUK
$97.5B
$1.7M 0.42%
21,233
-2,136
-9% -$173K
AAPL icon
72
Apple
AAPL
$4.9T
$1.69M 0.41%
29,872
+644
+2% +$33.5K
EGRX
73
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.66M 0.41%
24,000
– –
LMT icon
74
Lockheed Martin
LMT
$117B
$1.65M 0.41%
4,771
-221
-4% -$71.3K
SCL icon
75
Stepan Co
SCL
$1.33B
$1.59M 0.39%
18,333
+830
+5% +$71.5K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2018 Portfolio in Review

As of Q3 2018, Stanley-Laman Group held 282 positions worth $407M, down 8.6% from $445M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Stanley-Laman Group withdrew a net $52.4M in Q3 2018, closing 63 positions and reducing 110 holdings. Its most notable exit was Neurocrine Biosciences, an estimated $8.83M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Stanley-Laman Group opened a new position in Acceleron Pharma worth $7.16M.

  • Stanley-Laman Group's largest Q3 2018 buy was Acceleron Pharma: 125,020 shares worth $7.16M.
  • Stanley-Laman Group added most to Prudential Financial in Q3 2018, an estimated $152K increase.
  • Stanley-Laman Group's biggest Q3 2018 reduction was Hortonworks, Inc., cutting an estimated $629K.
  • Stanley-Laman Group fully exited Neurocrine Biosciences in Q3 2018, selling an estimated $8.83M.
  • Stanley-Laman Group's ten largest holdings make up 19% of its $407M portfolio in Q3 2018.
  • Stanley-Laman Group opened 19 new positions and closed 63 in Q3 2018.
  • Stanley-Laman Group's portfolio value fell 8.6% quarter-over-quarter to $407M.

Based on Stanley-Laman Group's 13F filing for Q3 2018, filed 30 Oct 2018.